OR WAIT null SECS
July 05, 2017
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
July 03, 2017
The Spanish CDMO has installed a new automatic capsule filling machine at its EU GMP-approved plant in Pamplona, Spain
July 02, 2017
Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment.
The BIOSTAT STR single-use bioreactor family from Sartorius Stedim Biotech is based on a conventional stirred-tank design.
Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.
Materials and equipment innovations have advanced tablet coating from sugar to copolymers and simplified pharma production.
New ADC therapies must overcome manufacturing challenges to reach market.
As commercial manufacturing considers single-use materials, a look shows how industry moved to the technology.
The more pharma science and technology change, the more business and policy concerns stay the same.
Biotech-based therapies and a move to single-use processes highlight recent industry changes.